NCI is moving toward adopting a formula that will fundamentally restructure the manner in which cancer centers are funded.
BORIS PASCHE has become director of the recently expanded comprehensive cancer center at Wake Forest Baptist Medical Center.
CURIE-CANCER, the body responsible for developing Institut Curie's industry partnership activities, and is renewing its partnership with DNA Therapeutics.
CAROL BIER-LANING will lead a new comprehensive head and neck cancer program launched by Cancer Treatment Centers of America at Midwestern Regional Medical Center.
JIALI HAN was named the Rachel Cecile Efroymson Professor in Cancer Research at the Indiana University Simon Cancer Center, pending approval by the IU board of trustees. He is also professor and inaugural chair of the Department of Epidemiology at the Fairbanks School of Public Health.
NCI has issued a report detailing a “scientific framework” for advancing research on pancreatic ductal adenocarcinoma, indicating potential new funding opportunities for genomic studies for early detection of pancreatic cancer.
Human papillomavirus vaccines are underused in the U.S. and need to be made a national public health priority, according to a report from the President's Cancer Panel.
President Barack Obama's $3.9-trillion budget proposal for the 2015 fiscal year would bump NIH funding up to $30.2 billion—a $200 million increase over fiscal 2014—and would include an additional $8 million for NCI, totaling $4.931 billion for the institute.
NIH has launched a systematic examination of its intramural program, which accounts for 11.1 percent of its $30 billion budget.
CLARIENT added the THxID-BRAF molecular diagnostic test, developed by BioMerieux Inc., to its service offerings.
